Researchers have developed a long-acting allosteric antagonist targeting the growth hormone receptor for the treatment of acromegaly. This advancement could enhance treatment options for patients suffering from this rare endocrine disorder.
development and characterization of a long acting allosteric growth hormone receptor antagonist for acromegaly
Original title: “Development and Characterization of a Long-Acting Allosteric Growth Hormone Receptor Antagonist for Acromegaly.”